The pathogenesis involves obesity-induced insulin resistance, compensatory hyperinsulinemia, and changes in sex hormones and insulin-like growth factor-1 (IGF-1) bioavailability, alongside elevated inflammation and oxidative stress. Here, IGF1 is linked to hyperinsulinism.